Liver/Biliary Disorders News

Liver cancer — the fastest-growing cause of cancer death in the U.S. — has been notoriously difficult to treat.

Lean and non-lean patients with nonalcoholic fatty liver disease were similar metabolically and had common risk factors, according to findings published in the Journal of Gastroenterology and Hepatology Open.

Predicted severe acute biliary pancreatitis treated with early endoscopic retrograde cholangiography with sphincterotomy did not reduce major complications or mortality compared with conservative treatment, according to a presenter.

Severe transplant-related maternal complication and offspring prematurity may occur at a higher proportion after liver transplant vs. the general population, but overall outcomes are positive, researchers reported at UEG Week Virtual.

Waist circumference independently correlated with the risk for advanced fibrosis among patients with type 2 diabetes, according to a presenter at the European Association for the Study of Diabetes Annual Meeting.

Fatty pancreas independently correlated with diabetes mellitus but not hypertension or dyslipidemia, according to research published in Clinical Gastroenterology and Hepatology.

Protara Therapeutics announced results of a study designed to further understand the incidence of intestinal failure-associated liver disease in patients dependent on parenteral nutrition.

Nonalcoholic fatty liver disease correlated with an increased long-term risk for cardiovascular events and may be an independent risk factor for CVD morbidity and mortality, according to research.

Pioglitazone was safe and effective in improving liver histology among patients with nonalcoholic steatohepatitis, according to a presenter at the Digital NAFLD Summit 2021.

Two doses of icosabutate were well tolerated and safe in patients with nonalcoholic steatohepatitis.